Letters Adverse drug reactions

Striving for better patient information on adverse drug reactions

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5513 (Published 18 September 2014) Cite this as: BMJ 2014;349:g5513
  1. Jan MacDonald, head of patient information quality1
  1. 1Medicines and Healthcare Products Regulatory Agency, London SW1W 9SZ, UK
  1. press.office{at}mhra.gsi.gov.uk

Tan and colleagues raise important issues about patients’ confidence in drugs.1 We know that adverse reactions are one of the key pieces of information that patients seek and about which they have most concern.2

In the UK, all drugs are accompanied by a patient information leaflet, which is drawn up in accordance with the drug’s marketing …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe